Background: Despite its high prevalence, most acute low back pain (ALBP) is nonspecifi c, self-limiting with no defi nable pathology. Recurrence is prevalent, as is resultant chronicity. Psychosocial factors (yellow fl ags comprising depression and anxiety, negative pain beliefs, job dissatisfaction) are associated with the development of chronic LBP. Methods: A national insurer (Accident Compensation Corporation, New Zealand [NZ]), in conjunction with a NZ primary health organization, piloted a strategy for more effective management of patients with ALBP, by following the NZ ALBP Guideline. The guidelines recommend the use of a psychosocial screening instrument (Yellow Flags Screening Instrument, a derivative of Örebro Musculoskeletal Pain Questionnaire). This instrument was recommended for administration on the second visit to a general medical practitioner (GP). This paper tests whether published cut-points of yellow fl ag scores to predict LBP claims length and costs were valid in this cohort. Results: Data was available for 902 claimants appropriately enrolled into the pilot. 25% claimants consulted the GP once only, and thus were not requested to provide a yellow fl ag score. Yellow fl ag scores were provided by 48% claimants who consumed two or more GP services. Approximately 60% LBP presentations resolved within fi ve GP visits. Yellow fl ag scores were signifi cantly and positively associated with treatment costs and service use, although the association was nonlinear. Claimants with moderate yellow fl ag scores were similarly likely to incur lengthy claims as claimants with at-risk scores. Discussion: Capturing data on psychosocial factors for compensable patients with ALBP has merit in predicting lengthy claims. The validity of the published yellow fl ag cut-points requires further testing.
Background
Low back pain (LBP) is a signifi cant public health problem in the Western world, with as many as 84% of the general population believed to experience LBP at some point in their lives (Walker 2000) . Despite its high prevalence, most LBP is typically nonspecifi c, with almost all events occurring in the absence of clearly defi nable pathology (NHMRC 2003) . Whilst acute LBP is typically self-limiting, recurrence is prevalent and chronicity not uncommon (Bekkering et al 2003; NHMRC 2003) . LBP impacts on the individual, and on workplaces, families and the wider community.
The New Zealand Accident Compensation Corporation (ACC) is a national compensable body. Its role, broadly speaking, is to provide insurance for all New Zealanders, injured in road accidents, at work, and in the community (ACC 2007) . LBP places a substantial burden on health care resources, with such injuries costing ACC an estimated NZ$130 million per annum. Despite this spending, ACC claimant outcomes from LBP are not always satisfactory.
The use of clinical guidelines has been proposed as a way of improving health care processes and outcomes (Grimshaw et al 2004; Barosi 2006) . Supporting an increasing consumer expectation of evidence-based health care, clinical guidelines are being produced for large numbers of conditions. LBP is no exception, with at least ten clinical practice guidelines currently in use around the world. Perceived benefi ts of the use of clinical guidelines include a reduction in inappropriate practice variations, increased clinical effi ciency and support, and better control of health care spending (Lenfant 2003; Grimshaw et al 2004) . The research evidence is equivocal however, regarding the real cost and health outcomes of guideline-based care.
Recent advances in understanding of factors associated with LBP have recognised the infl uence of psychosocial factors on health outcomes, with current LBP guidelines refl ecting this (Kendall et al 1997; Bekkering et al 2003; NHMRC 2003; Holohan et al 2006) . Psychosocial risk factors, including depression and anxiety, negative pain beliefs, low mood and job dissatisfaction, have strong associations with poor health outcomes and chronicity of LBP (Bekkering et al 2003; NHMRC 2003; ACC 2004) . Kendall (1999) proposes that many chronic pain behaviors are observable in the fi rst few days of incurring ALBP. However, few studies have investigated the effi cacy of strategies to prevent ALBP from developing into chronic pain (Newton-John et al 2001) .
Most LBP clinical guidelines consistently advocate early identifi cation of LBP sufferers with at-risk psychosocial symptoms and behaviors, so that early targeted interventions can be put in place (Kendall et al 1997; Bekkering et al 2003; NHMRC 2003; Holohan et al 2006) . The Yellow Flags Screening Instrument (YFSI) (Kendall et al 1997) is an early version of the Örebro Musculoskeletal Pain Questionnaire (Linton and Boersma 2003) . It is recommended as a mechanism to assess psychosocial factors associated with ALBP. Psychosocial factors include fear-avoidance behavior, low mood/withdrawal, expectation of passive treatment and negative pain beliefs (Kendall et al 1997; Turk 1997; Linton and Hallden 1998; Kendall 1999; Linton and Boersma 2003) . The YFSI provides the following risk thresholds and descriptors (Kendall et al 1997, p 34-35 ):
• 'Scores Ͼ105: "…will enable you to identify at least three-quarters of the long-term cases." • Scores 90-105: "This group will include a proportion who are at risk for medium-term problems." • Scores Ͻ 90: "Most of these patients will exhibit recovery within the expected time period.' The YFSI is reported to identify '75% cases correctly of those not needing modifi cation to ongoing management, 86% correct identifi cation of those who will have between 1 and 30 days off work, and 83% correct identifi cation of those who will have more than 30 days off work' (Kendall et al 1997, p 39) . There is scant literature which validates these claims in other ALBP populations.
This paper reports on the validity of the Kendall et al (1997) yellow fl ag score cut-points to predict LBP claims length (and higher claims costs) for ACC ALBP claimants during 2006.
Methods Ethics
Ethical approval for the study was provided by the University of South Australia Human Research Ethics Committee (Australia), New Zealand Health and Disability Northern Y Regional Ethics Committee, and an internal ACC Ethics Committee.
Setting
Auckland region, New Zealand.
Study background
ACC, in conjunction with a primary health organization (PHO), devised and piloted a strategy to facilitate more streamlined and effective management of patients with acute LBP, by following a 'guidelines-based' treatment protocol. PHOs are local structures for delivering and co-ordinating primary health care services. PHOs bring together doctors, nurses and other health professionals (such as Maori health workers, health promotion workers, dieticians, pharmacists, physiotherapists, psychologists and midwives) in the community to serve the needs of their enrolled populations. This pilot strategy was based on the New Zealand Acute LBP Guide (ACC 2004 ), a recommended clinical practice guideline (pathway) framed on a review of the relevant scientifi c literature within which the YFSI is embedded (Kendall et al 1997) . It was envisaged that this pilot strategy would result in better claimant health outcomes, with corresponding cost benefi ts to ACC. The pathway recommended five general medical practitioner (GP) occasions of service in the episode of care for ALBP, and the application of the YFSI at the second visit. An episode of care is a set of congruent health care visits (occasions of service) for the management of the one condition (Grimmer et al 2000) . If claimants had at-risk yellow fl ag scores, and/ or if their episode of care necessitated more than fi ve GP visits, then they should be referred to psychological services. A payment of over NZ$100 for the second visit was provided to GPs who assessed patients for yellow fl ags at the second visit, as per the ALBP protocol.
Yellow fl ag scores in a compensable New Zealand cohort suffering acute low back pain Subjects ACC claimants presenting to the GPs registered with the affi liated GP organization between February and December 2006 were eligible to be enrolled into the guidelines pilot program. The time period over which claimant data was analyzed was March-December 2006, which accounted for approximately 98% of the enrolments into the pilot program. Approximately 85% GPs in the PHO participated in the pilot program. The guidelines recommended up to fi ve visits to the participating GP as required, with the second visit being an extended consultation at which information on psychosocial factors (yellow fl ags) was recommended for capture, using a dedicated IT decision-making tool, linked to the GP practice management system. Claimants whose ALBP was not resolving after the 2nd GP visit were eligible, under the treatment guidelines, to be referred to specialist pain management services (Physiotherapy, Psychology). Repeat yellow fl ag scores were captured as required, at subsequent visits during the episode of care, if the claimant's symptoms were not resolving. Yellow fl ag assessment was however, not mandatory for claimants or GPs. Reasons for GPs not assessing claimants for yellow fl ags could be claimant refusal, GP disinterest, GP failure to follow the clinical pathway, or GP and claimant decision that suffi cient improvement in symptoms had occurred such that the claimant would require few further treatments (making yellow fl ag assessment unnecessary).
Red fl ags
Red fl ags are symptoms or history indicating immediate referral to a specialist. Red fl ags for acute LBP can include fractures, infection, symptoms of cancer, and psychiatric and neurological disturbances (NHMRC 2003) . The ACC clinical pathway recommended that claimants with suspected red fl ags be referred immediately for treatment elsewhere.
Yellow fl ags
The published classifi cations of psychosocial risks (measured as yellow fl ags) were applied to the claimant cohort in this pilot program (Linton and Hallden 1998) . However this data was not derived on a NZ-born population and therefore its utility had not been validated. Following the yellow fl ag risk thresholds and descriptors (Kendall et al 1997) , claimants with yellow fl ag scores were classifi ed Ͼ105 (high risk), between 90 and 105 (moderate to high risk) and 50-89 (moderate risk) (Kendall et al 1997; Linton and Hallden 1998) . Claimants with scores lower than 50 were not considered to be at-risk of chronic pain behaviors, and thus were designated as the comparison group for all analysis.
Claims data
Claims were analyzed as number of services within the episode of care, and the length of time over which the episode of care (open claim) extended (claims length). The number of days lost from work was also examined. ACC legislation allows for lost earnings compensation to be paid after seven days off work. Therefore, absences of less than seven days from work are not present in the data. Thus it is not known how many claimants took no days off work, or less than seven days. The number of claimants in this data set who took more than seven days off work because of their ALBP is therefore not representative of claimants who took no, or less than seven, days off work.
Data analysis
Deidentified amalgamated data was provided on ACC claimant data for the period of the pilot program. The dataset included information on number and type of health service consultations per event of acute LBP (episode of care), demographic information (age, gender, self-reported ethnicity), claim duration and total cost, the number and type of health contacts, 'red fl ag' status and 'yellow fl ag' scores (if provided). Raw claims data was tabulated using MS Offi ce Excel (Microsoft Corp., Redmond, WA, USA), and analysed using SAS Version 8.2 (SAS Inc., Cary, NC, USA).
The investigations reported in this paper considered only those claimants who consumed more than one GP visit. They were thus eligible to provide a yellow fl ag score on their second visit, as recommended in the guidelines. Gender, age and ethnicity characteristics, and claims length and cost, were described for those claimants who provided, or not, yellow fl ag scores using median (25th, 75th range) for the equal interval data, and percentages for the categorical data. Analysis of Variance models (for equal interval data) and chi square tests (for categorical data) were used to establish signifi cance (set at p Ͻ 0.05 for all statistical tests). Signifi cant F and chi square values, and degrees of freedom (df ) are reported.
Within the subgroup of claimants which provided yellow fl ag scores, the characteristics of the different yellow fl ag classifi cations (outlined by Linton et al 1999) were investigated in a similar manner. Univariate logistic regression models using independent categories of yellow fl ag scores were used to identify whether the yellow fl ag score classifi cations linearly predicted claims outcomes and costs. The comparison group was claimants with yellow fl ag scores 0-49 (considered to have low risk of chronicity). Signifi cant odds ratios were identifi ed when the 95% confi dence intervals (CIs) did not encompass 1. The confounding effect of ethnic status, gender and age on this association was then investigated using step-wise multivariate logistic regression models. The confounding effect in the multivariate regression models was assessed during construction of the stepwise models by the signifi cance of the amount of change in the Likelihood Ratio (df, p value).
Hypotheses underpinning testing
There is a positive linear relationship between yellow fl ag scores, claims length, and claims costs. Figure 1 outlines the consort diagram for the pilot program, in which 902 eligible claimants were appropriately enrolled into this pilot program, 223 claimants consulted a GP once only and thus did not enter the clinical pathway, and of the remainder, 328 provided yellow fl ag scores.
Results Claimants
Median age of the 902 eligible claimants was 38 years (25th% to 75th% 30-46 years) (range 16-72 years), with males predominating (58.8%). There was no signifi cant gender difference in mean age. These claimants selfreported ethnicity, comprising European (42.8%), Asian (12.8%), Maori (12.2%), Middle Eastern/Latin American/ African 1.4%, Pacifi c Islanders 18.7% and other (Indian, etc) (12.1%). The demographic profi le of the ACC cohort did not differ from that of the greater Auckland city area, North Shore City, or Manukau City (Statistics New Zealand 2002), suggesting generalizable fi ndings to other LBP sufferers.
Diagnosis was assigned by the treating GP using ACC codes. The predominant diagnosis was lumbar sprain (73.3%), followed by lumbar spine pain (7.8%), other (undefi ned) (7%), thoracic sprain (3.9%), lumbar disc prolapse with radiculopathy (3.1%), sacroiliac ligament sprain (2.2%), sciatica (1.8%), back sprain (0.6%), and lumbosacral strain (0.3%). There was no data available of inter-or intra-rater GP reliability when assigning these diagnostic codes, or the appropriateness of the diagnostic codes.
Claims information
The eligible claimants (N = 902) consumed 5976 health services during the pilot program (median 3 services per claimant, range 1-74) (25th% to 75th% 2-9). Claimants could not enter the ACC clinical pathway without an initial GP visit, which was the only contact for 223 claimants (24.7% total) (that is, they required no further treatment of any kind and thus did not proceed down the clinical path). These claimants were excluded from the analysis reported in this paper. A range of services were consumed by the remaining claimants (those recording two or more visits to health providers), namely physiotherapy (44.6%), GP (35%), acupuncture (8%), chiropractics (4.6%), diagnostic radiology (2.2%), osteopathy (1.9%), medical specialties (3.6%). Overall, this cohort cost ACC $275,783.54 (median cost $148.09 per claimant for an episode of care for acute LBP) (25th%-75th% $49.60 to $366.02).
Yellow fl ag scores
For the remaining claimants (N = 679), the clinical pathway recommended assessing psychosocial risk using the YFSI on the second GP visit. Yellow fl ags data was available for 328 claimants (48.8%) who consumed two or more GP (See Figure 1) .
Considering the claimant cohort which attended the GP for two visits or more, there was no signifi cant difference between claimants who provided yellow fl ag scores and those who did not (in age, gender proportions, diagnostic categories, occasions of service, length of episode of care, or the percentage of claimants who took more than seven days off work (and the number of days they took off work)). Occasions of service refl ected any health service consumption, not just general medical practitioners. There was a signifi cant difference in unadjusted claims costs however, between the two groups, with the yellow fl ag claimant group having high median costs which refl ected the increased payment for assessing yellow fl ag scores on an extended second visit consultation. When this payment was removed from the total claims costs for this group, the difference between groups was no longer signifi cant (adjusted median total cost for the yellow fl ag group $155.14 (25th% $78.40, 75th% $386.30). The comparison data is provided in Table 1 .
To add weight to the similarity in service delivery consumption patterns (and adjusted total costs) of the claimants who provided, or not, yellow fl ag scores within this cohort, similar distribution of the numbers of occasions of service in the claimants' episodes of care for their ALBP is provided in Figure 1 . Thus the fi ndings from the claimants who consumed two or more GP visits and provided yellow fl ag scores are generalizable to those who also consumed two or more GP visits, but did not provide yellow fl ag scores. 
Claimants with yellow fl ag scores
Claimant yellow fl ag scores ranged from 10 to 146. Of the claimants who provided yellow fl ag scores, N = 67 (20%) had scores less than 49 (deemed to be low risk of developing chronic LBP). N = 175 (52.9%) had yellow fl ag scores between 50-89 (some risk of chronic LBP, whilst N = 45 (13.6%) had scores between 90 and 105 (moderate to high risk of chronic LBP. Forty-four claimants (13.3%) had at-risk scores Ͼ105. This indicated, using the scoring criteria, that over 73% of the claimants who provided yellow fl ag scores had no, or minimal, risk of developing persistent pain behaviors.
Demographic and service consumption differences in yellow fl ag claimant groups
Demographic characteristics of the claimants with yellow fl ags are reported in Table 2 . There was no need to adjust the cost of claims in this yellow fl ags subset as all GPs had the opportunity receive the extended visit payment for collecting yellow fl ag scores on the second visit. There was no signifi cant difference in the frequency of gender, common diagnostic condition (lumbar sprain) and the number of days off work greater than seven, across the yellow fl ag groups.
There was a signifi cant difference across the groups in the frequency of ethnicity (chi square 35.6 18df ) p Ͻ 0.05, as well as signifi cant differences (all with 3df) in the median length of claims (F = 11.5), the number of occasions of service in the episode of care (F = 8.54), and total claims costs (F = 8.9) ( p Ͻ 0.05). Occasions of service refl ected any health service consumption, not just general medical practitioner visits. There was also a signifi cant difference in the percentage of claimants in each yellow fl ag category who took more than seven days off work (F = 7.8) ( p Ͻ 0.05).
Ethnic differences
The significant influence of ethnicity on psychosocial factors is evidenced by the distribution of yellow flag scores (Figure 2 ) in which the score distribution of the Middle Eastern/Latin American/African group scores was signifi cantly higher than the 75th% of the other ethnic groups. Differences in service costs are illustrated in Figure 3 by the signifi cantly higher distribution of scores for the Asian claimants compared with all others.
Treatment costs
Compared to claimants with yellow fl ag score less than 50 (not at-risk of chronic pain behaviors), all other claimants with yellow fl ag scores were signifi cantly more likely to incur treatment costs in excess of the overall median cost per claimant (NZ$148.09). Signifi cance was indicated as the 95% CI did not encompass 1 for any of the associations. For the low risk of LBP chronicity (yellow fl ag scores of 50-89, the unadjusted odds of incurring claims costs in excess of $148.09 was 6.8 (95% CI 4.5-10.3). For the moderate risk Yellow fl ag scores in a compensable New Zealand cohort suffering acute low back pain of LBP chronicity group (yellow fl ags scores 90-105), the unadjusted odds was 15.6 (95% CI 5.5-44.1), and for the high risk of LBP chronicity group (yellow fl ag score Ͼ105), the unadjusted odds was 11.9 (95% CI 4.6-30.5). This supports the general hypothesis that the higher yellow fl ag scores, the greater the likelihood of higher treatment costs. Chronicity reflected by long claims: Considering claimants with yellow fl ag scores, and considering the median overall claims length (11 days), compared to claimants with low yellow fl ag scores (less than 50), 'high-risk' claimants (yellow fl ag scores Ͼ105) were signifi cantly (seven times) more likely to have a claim lasting greater than the median claims length (unadjusted odds ratio [95%CI] 7.1 [2.7-19.1]). Claimants with yellow fl ag scores between 50-89 were also signifi cantly more likely to become chronic (unadjusted odds ratio (95%CI) 2.5 (1.1-5.9), however claimants scoring between 90-105 did not have a signifi cantly elevated risk compared with the not-at-risk claimants (unadjusted odds ratio (95%CI) 1.9 (0.6-5.5).
Adjusting for confounding
Significant change in the likelihood ratio (LR) in the stepwise multivariate logistic regression models indicated that ethnicity was a signifi cant confounder on the association between yellow fl ags classifi cations and total cost (LR 20.2, 8df, p Ͻ 0.05) and yellow fl ags classifi cations and claims length (LR 12.3, 8df, p Ͻ 0.05). The addition of gender or age did not signifi cantly increase the LRs (LR 3.1, 9df; LR 1.9, 9df, respectively). The adjusted odds of claimants in the different yellow fl ags categories incurring costs higher than $148.09 or claims lasting longer than 11 days is reported in Table 2 . The probability that higher yellow fl ag scores will predict high cost and claims length was increased in all yellow fl ag score categories, compared with the low risk category. There was similar risk of high cost claims occurring in the moderate, and moderate to high categories (in the range of 2-3 times the risk), with strongly elevated probability (nearly 8 times the risk) in the at-high risk group. Comparing the unadjusted and adjusted odds ratios for high cost, it appears that the confounding effect of ethnicity was greatest in the moderate to high risk yellow fl ag score category, as thus group showed the greatest change between unadjusted and adjusted odds. There was a different and linearly increasing risk pattern across the categories for long claims length, ranging from OR of three in the moderate risk group, six in the moderate to high risk group, and nine in the at-risk group). The moderate to high risk group again showed the greatest effect of deconfounding.
Claims lasting 90 days or more
The yellow fl ags classifi cations claim to be able to predict claimants who will have extended claims. ACC defi nes extended claims as those lasting greater than three months (Ͼ90 days). Overall, of all claimants in the ACC pilot cohort (N = 902), 138 (15.3%) had claims which were not closed within 90 days. Sixty-three of this subset of claimants (45.7%) did not have a recorded yellow fl ag score, indicating that their care had not complied with the ACC clinical pathway.
Confounding by ethnicity but not by gender or age was the same for this analysis, as indicated by the change in LRs at each step (LRs 19.6 8df, 3.8 9df, 3.9 9df, respectively). Considering the adjusted odds ratios from the step wise regression models, there were signifi cant and elevated probabilities that moderate, and at-risk yellow fl ag classifi cations would predict claims lasting longer than 90 days, compared to low risk yellow fl ag scores. However, despite deconfounding by ethnicity, the risk of claims Ͼ90 days in the moderate to high risk yellow fl ag group was no different to the low risk group, as outlined in Table 3 . These fi ndings suggest that the classifi cations of yellow fl ag scores require revising to more accurately predict lengthy claims.
To consider the sensitivity and specifi city of the proposed yellow fl ag score classifi cations in this cohort of ALBP claimants, the number of claimants in the four yellow fl ag score categories with respect to extended (90 + days) claims length is presented in Table 4 . The YFSI performed best when identifying claimants with low yellow fl ag scores who would not become chronic cases (specifi city of 84.6%). Sensitivity was poorer (26.7%), as only 20 of the 75 claimants with a claim lasting in excess of 90 days, had yellow fl ag scores greater 105, and were correctly identifi ed as at high-risk for chronicity. Of the 44 claimants who had at-risk yellow fl ag scores (Ͼ105), less than half became chronic cases. Conversely just over one-fifth of low to moderate risk claimants (scores 50-89), and just under one-fi fth of moderate to high risk claimants (scores 89-105) had extended claims, which refutes the notion that high yellow fl ag scores are sensitive predictors of lengthy claims. Considering claimants with yellow fl ag scores of 90+, only 45.6% were correctly identifi ed as consuming claims longer than 90 days, which is considerably lower than the predicted percentage (89%) (Linton and Boersma 2003) .
Referral
Less than a third (31.8%) of claimants deemed at 'high-risk' due to their yellow fl ag score were referred to psychological services, as recommended in the clinical pathway. Furthermore, of those who were referred, claimant utilization of these services was poor, with only three claimants completing treatment. Given the constraints on the data provided by ACC for this paper, it could not be determined why this low referral or completion rate occurred.
Discussion
This paper reports on a rare opportunity to examine psychosocial risk related to cost and claims length, in a large northern-New Zealand cohort of compensable claimants with ALBP. Claimant demography is representative of the wider northern New Zealand population. The clinical pathway underpinning the management of claimants with ALBP provided fi nancial incentives for GPs to collect yellow fl ag scores from claimants who attended twice or more. Of the ACC claimants who had this opportunity to provide yellow fl ags scores, the characteristics of the claimants who provided yellow fl ag scores were no different from those who did not provide yellow fl ag scores. We believe that this sample is generalizable to other compensable claimants with ALBP.
Data limitations
Of those claimants who attended their GP at least twice and thus were eligible to provide a yellow fl ag score, less than half did so. This raises questions about yellow fl ag scores for the noncompliant subset. In health services research which evaluates processes and outcomes of service delivery programs applied in 'everyday' settings, it is not possible to predict how individual practitioners and claimants will behave, despite them agreeing to comply with established Grimmer-Somers et al program protocols. On refl ection, at least 100 claimants who did not provide a yellow fl ag score can potentially be accounted for. Figure 1 reported that approximately 25% of the claimants who consumed two visits or more, and provided no yellow fl ag scores, only consumed two occasions of service within their episode of care. Furthermore approximately 10% only consumed three occasions of service in their episode of care. It is possible that, if the patient and GP predicted the imminent closure of the ALBP episode of care, they may have legitimately decided not to record a yellow fl ag score. This could be verifi ed by the nonpayment of the second visit payment to these claimants' GPs. If this assumption is correct, the percentage of eligible yellow fl ag claimants who did not provide yellow fl ag scores, and, could be reduced to approximately 30% for whom no reasonable explanation could be found other than noncompliance.
There is little rationale in the ALBP clinical guidelines (ACC 2004) for collecting yellow fl ag scores on the second GP visit. While chronic pain behaviors are believed to be exhibited early in an episode of ALBP, it is not known whether capture of information on psychosocial risk at the fi rst, second or subsequent visits to the GP is appropriate. Despite the increased second visit payment for assessing yellow fl ag scores. GPs may not have been suffi ciently motivated or confi dent to capture this information from their patients, particularly if these practice behaviors were foreign to them. Further information needs to be obtained from GPs and their patients regarding their perspectives on the use of a standard protocol for the management of ALBP. Crawford and colleagues (2007) suggests that for many GPs, identifi cation and management of psychosocial factors depends on their world-view and orientation to the biopsychosocial model of pain. This may be refl ected in the infrequent GP use of the YFSI in the management of patients with ALBP, despite the payment. Many GPs report treating patients purely according to biomedical principles initially, until a lack of progress was evident (Crawford et al 2007) . Thus administering the YFSI on the second GP visit (as stipulated in the ACC clinical pathway) may not have coincided with GPs' beliefs or usual management practices. It may also not have been acceptable to claimants. In the same vein, referral of claimants with high yellow fl ag scores to psychological services may not have coincided with GPs or patients' beliefs, which may have accounted for the low psychological counselling referral and treatment completion rate. These issues need to be better understood, as compliance by clinician and patient with any agreed clinical protocol is essential to its effectiveness (Grimshaw et al 2004) .
Yellow fl ag scores
Yellow fl ag scores were signifi cantly confounded by ethnicity but not gender or age. Claimants of middle Eastern ethnic background had signifi cantly higher yellow fl ags than any other racial group. Considering the overall group median scores, increasing yellow fl ag scores were generally linearly related to higher claims costs and claims length. This concurs with the claims of the YFSI developers that the higher the yellow fl ag score, the more likely it is to predict long claims.
Claims longer than 90 days
When predicting claims lasting longer than 90 days however, despite deconfounding for ethnicity, claimants with scores between 50-89 (who traditionally represent a low to moderate risk (Linton and Hallden 1998; ACC 2004) ), recorded a stronger probability of incurring a lengthy claim than claimants scoring 90-105. This fi nding challenges the notion that claimants with scores less than 90 are considered together as posing similarly and low level of risk for poor outcomes (Linton and Hallden 1998; ACC 2004) .
The sensitivity of the YFSI high-risk classifi cation was poor (less than 30%) and thus it needs to be reconsidered for use in this NZ cohort of ALBP claimants. Given the wide score range available for 'low-risk' claimants (50 points), in comparison to the available range of low to moderate risk (39 points) and moderate to high risk (15 points), it is perhaps not surprising that different risk profi les exist within each classifi cation, particularly given the different ethnic profi les in each yellow fl ag score classifi cation. The intention for the YFSI is to assist in identifying claimants to whom appropriate allocation of additional resources would be benefi cial (Linton and Hallden 1998) . From these results, there appears to be a considerable proportion of claimants who are being overlooked. Claimants previously deemed at low or moderate risk may still benefi t from referral to other services, such as counseling. Further investigation of yellow fl ag score classifi cations with respect to ethnicity, Yellow fl ag scores in a compensable New Zealand cohort suffering acute low back pain and increased claims cost, lengthy claims and development of chronic pain is warranted.
Conclusion
For those individuals whose ALBP threatens to take longer to resolve, there appears to be merit in embedding an assessment of psychosocial factors within a clinical pathway. This claim is supported by the generally linear association between yellow fl ag scores, treatment costs and claims length. However the YFSI requires testing in other ALBP populations to improve the sensitivity of its high score classifi cations in detecting individuals who are likely to have extended claims length (for instance greater than 90 days). Although the specifi city of the YFSI was high, the high percentage of claimants who scored low on the YFSI yet consumed lengthy claims requires investigation with respect to yellow fl ag score range, and ethnicity.
Approximately 60% ALBP presentations in this sample resolved within fi ve GP visits (as anticipated by the ACC clinical pathway). This describes the natural progression of, and expected compensable costs related to, ALBP. The standard ALBP protocol of applying the YFSI at the second GP visit needs to be revisited in light of the number of claimants who did not comply. These potentially included those who ceased care after the second or third GP visit, those claimants whose psychosocial risks were assessed as high, but did not consume lengthy episodes of care, and those claimants whose risks were assessed as low, and who had long claims.
